Technology | February 08, 2010

Single Platform Monitors Devices from Various Pacer, ICD Makers

The OneView system can help manage data from ICDs and pacemaker devices from multiple manufacturers. St. Jude is a registered trademark of St. Jude Medical


February 8, 2010 – Partnering with leading implantable cardioverter defibrillators (ICD) and pacemaker manufacturers, ScottCare Corp. has consolidated device information into one common platform with enhanced reporting and analysis capabilities. The newst addition to the CardioView Dx suite of diagnostic solutions is OneView, designed to manage all pacer and ICD patients and information.

The company will highlight the new software solution at the American College of Cardiology (ACC) 2010 meeting in Atlanta, March 14-16.

OneView simplifies clinicians’ workflow and is not device-centric, allowing clinicians to focus on managing patient information, not navigating multiple device manufacturers’ Web sites.

The OneView solution captures all relevant ICD data, including device specifications, measurements for every session, settings, episode details, reports, and physician sign-off.

The patient-centric interface allows the clinician to search by patient without knowing the device information first. The system enables the user to query almost any criteria imaginable, making it ideal for researchers. Also, users can easily identify patients with specific leads. OneView also provides insight into historical patient trends and other critical clinical data over time, helping clinicians prioritize patients with more severe issues. Data can be gathered from almost anywhere, as it supports remote interrogation, in-person interrogation and in-person programming.

The CardioView Dx suite offers a single platform solution for ambulatory monitoring and diagnostics. ScottCare also offers solutions for Holter monitoring, TeleSentry Multi-Parameter Ambulatory Telemetry, arrhythmia event monitoring and ambulatory blood pressure monitoring.

For more information: www.scottcare.com


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now